Daily Stock List
Medipattern Corp. (MKI.V)
Today we are highlighting Medipattern Corp. (MKI.V), here at the QualityStocks Daily Newsletter.
Founded in 1999, Medipattern Corp. is a pioneer in the development of imaging software solutions that help medical practitioners to understand better lesions and critical anatomy. The Company uses their Cadenza™ technology to process images, finding the salient region of interest and presenting them in 2D and 3D formats that enhance the reader's perception. Medipattern Knowledge-based Imaging (MKI) is the core expertise in the Company's patented Cadenza™ Technology Suite. Medipattern has their headquarters in Toronto, Ontario.
Through using the Company's patented Cadenza™ Technology Suite to identify, render, characterize and visualize medical abnormalities, physicians may deliver improved patient care. Medipattern products increase accuracy, streamline workflow and improve the bottom line for practices. Their products include their first-to-market, award-winning B-CAD® and their latest Visualize: Vascular™.
Medipattern garners their primary source of revenue from globally recognized resellers. The Company's products serve two medical market segments: vascular imaging and women's health.
B-CAD® is a leading computer aided detection (CAD) solution provider to the global women's health market. B-CAD® is the first FDA-cleared software used for the detection and characterization of lesions found in breast ultrasound images. Internationally, B-CAD became the first breast ultrasound CAD to receive SFDA clearance in China.
Furthermore, Medipattern has taken advantage of the Cadenza platform to create a morphology tool for breast magnetic resonance imaging (MRI), making Medipattern the first company to develop multi-modality imaging technology spanning ultrasound and MRI. The rights for B-CADmri were subsequently licensed exclusively to Sentinelle Medical, Inc.
Recently, Medipattern reported third quarter highlights and results from the Company's 2012 financial year, to March 31, 2012. They installed Visualize: Vascular™ in 23 facilities, which have a combined 154 sites. They increased scanning volumes month over month (January (17), February (83) and March (248)). They also expanded sales into mobile diagnostic providers with multiple customers; continued the Visualize: Vascular roll out expanding to the Southeastern United States; and reinforced clinical performance with a case study showing that Visualize: Vascular correctly identified patients with severe Stenosis that Doppler ultrasound technology did not find.
Since the end of the aforementioned quarter, Medipattern announced that they signed a binding letter agreement with MYTRAK® Health System, Inc. to combine their technologies and launch a new personalized mobile health business called MyTrak Personal Health Solutions. This will focus on monitoring physical activity for the management of Metabolic Syndrome by leveraging MYTRAK's proven wearable mobile technology platform to complement their core proprietary cardiovascular visualization and image analysis business.
Medipattern Corp. (MKI.V), closed on Tuesday at $0.26, up 4.00%, on 45,000 volume. The 52-week low/high is $0.14/$0.40.
Medizone International, Inc. (MZEI)
SmallCapVoice reported this month on Medizone International, Inc. (MZEI), SmarTrend Newsletters did earlier, and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Medizone International, Inc. is a research and development company that lists on the OTC Bulletin Board. The Company engages in developing AsepticSure™ technology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools, clean rooms, hotels, cruise ships, and other critical infrastructure. Medizone International has their headquarters in Sausalito, California.
Medizone is engaging in initial production of their modular design AsepticSure™ Decontamination Systems. A government variant is undergoing testing for bio-terrorism counter measures for building remediation. Hospital beta testing of the Company's AsepticSure™ production prototype took place in October of 2010. The trial results were deemed highly successful. The Company is currently preparing for full-scale hospital trials in Canada and the United States. The anticipation is that these will begin in the second half of 2012.
The AsepticSure™ hospital sterilization system is a portable, affordable, easily operated system that trained maintenance staff can use. It is placed in the center of the room to be cleaned. Vents and doors are sealed with an easily and cleanly removable 3M-tape product. The AsepticSure™ equipment is turned on from outside of the room by way of a remote wireless computer interface. The room is filled with a unique and patented gas formula that is ozone (O3) based to specific humidity and charge strength.
Following the charge period, the sterilization process is remotely turned off. A separate technology is employed that restores the atmosphere inside the room to EPA standards. The entire process, start to finish, takes 80 to 90 minutes. Then the room will have been cleared of pathogens to the 6 log sterilization standard.
In April, Medizone International announced that the first production unit of their AsepticSure disinfection technology was successfully completed by their manufacturing partner, SMTC Corp. This month, Medizone International announced that in achieving 100 percent kill rates with TB in three successive trials, the Company had achieved another important milestone in their understanding of the antimicrobial limits of their recently launched disinfection technology, AsepticSure™.
Medizone International, Inc. (MZEI), closed on Tuesday at $0.16, up 6.1%, on 44,802 volume with 6 trades. The average volume for the last 60 days is 126,785. The 52-week low/high is $0.11/$0.28.
Access Pharmaceuticals, Inc. (ACCP)
Daily Markets, Oakshire News Bulletin, FeedBlitz, PennyOmega, and Proactivecrg reported previously on Access Pharmaceuticals, Inc. (ACCP), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Access Pharmaceuticals, Inc. is a biopharmaceutical company with corporate headquarters in Dallas, Texas. The Company is leveraging their proprietary drug-delivery platforms to develop treatments in the areas of oncology, cancer supportive care and diabetes. A number of their products are based on Access' proprietary nanopolymer technologies that provide enhanced drug delivery options for new and approved pharmaceutical active ingredients. Access Pharmaceuticals shares trade on the OTC Bulletin Board.
The Company's products include MuGard™. It has received FDA marketing clearance for the management of patients with mucositis. MuGard is a novel; ready-to-use mucoadhesive oral wound rinse and coating for the management of oral mucositis. Oral mucositis is a debilitating side effect of many anticancer treatments, characterized by inflammation and erythema or ulcerations throughout the oral mucosa.
Their products also include ProLindac™, a second generation DACH Platinum in Phase 2 clinical testing of patients with ovarian cancer. In addition, their products include Thiarabine™, a novel nucleoside analog that has demonstrated pre-clinical and clinical activity in certain cancers. It is currently in a Phase 1/2a trial in hematological malignancies at M.D. Anderson Cancer Center in Houston, Texas.
Additionally, Access Pharmaceuticals has other advanced drug delivery technologies. These include CobaCyte™-mediated targeted delivery and CobOral-oral drug delivery, the Company's proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism.
Today, the Company announced that the results of a recent interim analysis of data from an ongoing MuGard clinical trial will be presented at a joint international symposium of the Multinational Association of Supportive Care in Cancer (MASCC) and the International Society of Oral Oncology (ISOO) on Supportive Care in Cancer. A podium presentation will be made by one of the lead investigators in the study on Thursday June 28, 2012. Results will be presented in a poster displayed on Friday June 29, 2012.
The annual MASCC/ISOO Symposium is the preeminent international conference to focus on supportive care in oncology. It will take place this week at the Hilton New York Hotel on Thursday, June 28-Saturday, June 30.
Access Pharmaceuticals, Inc. (ACCP), closed on Tuesday at $0.70, up 7.69%, on 68,312 volume with 24 trades. The average volume for the last 60 days is 43,895. The 52-week low/high is $0.45/$2.50.
China Auto Logistics, Inc. (CALI)
Dynamic Wealth Report, Momentum Traders, Greenbackers, Dubai Penny Stocks, and Global Equity Report reported previously on China Auto Logistics, Inc. (CALI), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
China Auto Logistics, Inc. operates www.cali.com.cn, one of the leading automobile sites for car dealers and consumers of vehicles and auto-related services in China. In addition, the Company is one of China's top sellers of luxury imported cars and a leading developer of websites for buyers and sellers of imported and domestic automobiles. They also operate through a service contract the largest imported auto mall in Tianjin, China. China Auto Logistics has their corporate headquarters in Tianjin.
The Company is China's number one wholesaler of imported luxury vehicles. They are also China's leading provider of "one stop" auto-related logistical and financial services with a network of more than 3000 automobile dealers throughout the country. In 2010, China Auto Logistics established www.cali.com.cn. On this portal, viewers have one-click access to three of the leading automobile sites in China developed and operated by the Company.
China Auto Logistics website for imported car dealers and buyers, www.at188.com, is the sole on-line site in China for complete, up-to-date information on imported vehicle sales, parts and pricing, and the Company's auto-related services, including short-term dealer financing. Their www.at160.com site provides the most comprehensive, up to date information on domestic vehicles in numerous cities throughout China.
The Company also has their www.goodcar.cn. This site is where the fast growing automobile driver population in China can obtain coupons and memberships providing discounts on an array of auto services.
Last month, China Auto Logistics reported that first quarter revenues in 2012, benefitting from the continuing strong demand in China for luxury vehicles, rose 31.7 percent to $107.45 million compared with $81.57 million a year earlier. At the same time, the Company continued to shift their focus from web-based advertising sales to further reshaping their online platforms into opportunities for increased auto sales and high margin auto related services growth.
Therefore, despite continued growth in the Company's other auto-related services businesses, including a 186 percent increase in finance services revenues, lower results in web-based advertising sales led to an approximately 24 percent decline in net income to $1,581,477, or $0.07 per share in this year's first quarter, from $2,077,134 or $0.11 per share in the first quarter of 2011.
China Auto Logistics, Inc. (CALI), closed on Tuesday at $0.40, up 8.11%, on 3,450 volume with 7 trades. The average volume for the last 60 days is 14,993. The 52-week low/high is $0.35/$3.80.
Polaris Minerals Corp. (PLS.TO)
We are reporting today on Polaris Minerals Corp. (PLS.TO), here at the QualityStocks Daily Newsletter.
Polaris Minerals Corp. engages in the development and operation of construction aggregate properties and projects. The Company exclusively focuses on the development of quarries and the production of construction aggregates in British Columbia for marine transport to urban markets on the Pacific coasts of North America to meet growing local supply deficits. Polaris Minerals' shares trade on the Toronto Stock Exchange. The Company is based in Vancouver, British Columbia. They also have offices in Port McNeill, British Columbia, and Richmond, California.
Polaris Minerals' construction aggregates interests consist of an 88 percent ownership in the Orca Sand and Gravel Quarry, a 70 percent ownership in the Richmond Terminal in California, which receives and distributes the Orca products, and a 70 percent ownership in the Eagle Rock Quarry Project. Moreover, the Company has certain rights to property in the Port of Long Beach, California, which they intend to develop in the future as a receiving terminal to access the Los Angeles area market.
In 2007, the Company commenced shipping sand and gravel from the Orca Quarry to San Francisco Bay, Vancouver and Hawaii. In 2008, Polaris formed a strategic alliance with Cemex USA, Inc., a major international construction materials company. The alliance established Polaris as the exclusive supplier of marine-transported aggregates to Cemex in northern California.
Polaris has secured marine transportation under a 20-year shipping agreement with CSL International, Inc., operator of the world's largest self-discharging fleet of bulk carriers. Polaris also owns 70 percent of the proposed Eagle Rock Quarry, a very large, permitted, high quality granite resource located near Port Alberni, British Columbia, which they expect to develop in the future when market conditions allow
In May, Polaris advised that their joint venture subsidiary, Cemera Long Beach LLC entered into a Purchase and Sale Agreement (PSA) in respect of the freehold land that they jointly own on Pier B in the Port of Long Beach, California. The parties to the PSA are Cemera and Baker Cold Storage, Inc. dba Castle & Cooke Cold Storage - Vernon, a large California-based operator of cold storage facilities that requires the land for business development purposes. The expectation is that the sale can be completed during this financial year. At that time, Polaris will receive approximately $12 million from the sale, net of closing costs and commissions.
Polaris Minerals Corp. (PLS.TO), closed on Tuesday at $0.60, even with yesterday’s close, on 13,350 volume. The 52-week low/high is $0.20/$0.98.
China Carbon Graphite Group, Inc. (CHGI)
Greenbackers reported recently on China Carbon Graphite Group, Inc. (CHGI), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
China Carbon Graphite Group, Inc. (China Carbon), through their affiliate, Xingyong Carbon Co., Ltd., manufactures graphite and carbon based products in China. The Company is the largest wholesale supplier of fine-grain and high-purity graphite in China and one of the nation's top manufacturers of carbon and graphite products. Since their establishment, China Carbon has patented the molding process for high density, high strength, and wear resistant graphite material as well as a double-sided molding machine.
The Company has a technology cooperation agreement with Hunan University. Hunan is the only university in China that offers a major in carbon studies. China Carbon also has a technology cooperation agreement with Tsinghua University, one of China's most distinguished universities.
Fine grain graphite is used extensively in smelting for colored metals and rare earth metal smelting as well as the manufacture of molds. High purity graphite is used in metallurgy, mechanical industry, aviation, electronic, atomic energy, chemical industry, food industry and an assortment of other fields.
In September 2007, China Carbon was approved and designated by the Ministry of Science & Technology as a "National Hi-tech Enterprise," a distinction that they still hold. Of the more than 400 carbon graphite producers in China, China Carbon is the only non-state-owned company to receive this honor.
Recently, China Carbon announced their financial results for the first quarter ended March 31, 2012. The Company had sales of $10.1 million in Q1 2012 compared to sales of $11.5 million in Q1 2011, a decrease of $1.4 million. China Carbon's Q1 2012 sales included $1.1 million in graphite electrodes, $4.5 million in fine grain graphite, and $4.4 million in high purity graphite.
The Company's net income was $0.25 million in Q1 2012 as compared to $0.33 million in Q1 2011, a decrease of $0.8 million. Gross profit margin grew from 22.5 percent in Q1 2011 to 29.0 percent in Q1 2012. China Carbon continues to advance their product mix optimization process, with higher margin products made from fine grain and high purity graphite key development priorities.
China Carbon Graphite Group, Inc. (CHGI), closed on Tuesday at $0.55, even with yesterday’s close, on 26,450 volume with 9 trades. The average volume for the last 60 days is 23,235. The 52-week low/high is $0.38/$1.26.
NXT Energy Solutions, Inc. (NSFDF)
SmarTrend Newsletters reported recently on NXT Energy Solutions, Inc. (NSFDF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
NXT Energy Solutions, Inc. is an international airborne geophysical service company utilizing their proprietary SFD® (Stress Field Detection) technology. SFD® provides a unique geophysical indicator that can be used early in the exploration cycle to provide an independent assessment of reservoir potential. When combined with seismic and other geologic data, SFD® can significantly reduce exploration risks and costs. NXT Energy Solutions lists on the OTC Bulletin Board. The Company has their headquarters in Calgary, Alberta.
NXT Energy Solutions' proprietary airborne SFD® survey system provides a proprietary survey method that can be used onshore and offshore to identify potential hydrocarbon traps and reservoirs remotely. The SFD® survey system enables the Company's clients to focus their hydrocarbon exploration decisions concerning land commitments, data acquisition expenditures and prospect prioritization on areas with the greatest potential. SFD® is environmentally friendly and unaffected by ground security issues or difficult terrain.
The Company's clients utilize SFD® to make time-critical regional exploration decisions about acquiring/relinquishing lands. SFD® has successfully reduced the need for conventional airborne and 2D reconnaissance surveys. SFD® deliverables include a report that identifies and ranks areas for trap and reservoir prospectivity. SFD® interpretation results may be gridded to create a prospectivity map.
At the end of May, NXT Energy Solutions announced their financial and operating results for the three months ended March 31, 2012. The Company had record quarterly revenue of $2.8 million. They had earnings of $338,000 versus a loss of $793,000 in 2011. In addition, they had an EPS of $0.01 versus a loss of $0.02 in 2011. Furthermore, the Company has a backlog of US $2.66 million of signed contracts, as well as a Letter of Intent (LOI) for US $1.0 million with a repeat customer.
NXT Energy Solutions' Q1 results reflect the completion of the SFD® survey on four exploration blocks in Colombia. Two additional survey contracts that were conducted in Argentina and Guatemala are planned to be completed in Q2. Following this, additional progress billings of US $1.1 million will be issued and US $2.3 million of survey revenue will be recognized.
NXT Energy Solutions, Inc. (NSFDF), closed on Tuesday at $0.79, up 1.95%, on 1,000 volume with 2 trades. The average volume for the last 60 days is 8,716. The 52-week low/high is $0.49/$1.29.
Ultrapetrol (Bahamas) Ltd. (ULTR)
Ultra Stock Picks and StreetInsider reported earlier on Ultrapetrol (Bahamas) Ltd. (ULTR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Ultrapetrol (Bahamas) Ltd. is an industrial transportation company serving the marine transportation needs of their clients. The Company serves the shipping markets for containers, grain and soya bean products, forest products, minerals, crude oil, petroleum, and refined petroleum products, and the offshore oil platform supply market with their extensive and diverse fleet of vessels. Ultrapetrol operates in three segments of the marine transportation industry: River, Offshore Supply, and Ocean. The Company has their corporate headquarters in Nassau, the Bahamas.
Their fleet of vessels includes river barges and pushboats, platform supply vessels, tankers and two container feeder vessels. The Company's River Business is the largest owner and operator of river barges and pushboats that transport dry bulk and liquid cargos through the Hidrovia Region of South America.
Ultrapetrol's Offshore Supply Business owns and operates vessels that provide critical logistical and transportation services for offshore petroleum exploration and production companies. This is primarily in the coastal waters of Brazil and the North Sea. The Company's Ocean Business operates eight oceangoing vessels, including four Product Tankers, which they employ in the South American coastal trade where Ultrapetrol has preferential rights and customer relationships, one container vessel, one 43,000-dwt petroleum product tank barge, and one Oceangoing Pushboat.
Recently, the Company announced financial results for the first quarter ended March 31, 2012. Total revenues for the first quarter 2012 were $64.5 million as compared with $58.3 million in the same period of 2011. Adjusted net loss for the first quarter of 2012 was $(13.1) million, or $(0.44) per share as compared with a net loss of $(6.6) million, or $(0.22) per share, during the same period of 2011.
At the end of May, Ultrapetrol announced the sale of 14 wet and dry barges to a third party in Colombia. The barges are scheduled for delivery in the second half of 2012. They will provide the Company with proceeds of $20.3 million, of which the buyer has advanced 50 percent.
Ultrapetrol (Bahamas) Ltd. (ULTR), closed on Tuesday at $1.21, down 3.20%, on 48,030 volume with 331 trades. The average volume for the last 60 days is 141,988. The 52-week low/high is $1.31/$5.34.
USA Recycling Industries, Inc. (USRI)
The QualityStocks Daily Newsletter would like to spotlight USA Recycling Industries, Inc. (USRI). Today, USA Recycling Industries, Inc. closed trading at $0.09, up 5.88%, on 1,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 17,242, and its 52-week low/high is $0.03/$0.14.
USA Recycling Industries, Inc. reported today that the company will provide its scrap metal collection services to cover the U.S. branch/site facility footprint (including Hawaii/Alaska) of top global elevator company, ThyssenKrupp Elevator AG, which has some 46k employees worldwide in over 150 countries (driving sales of some $6.61 billion in fiscal 2010-2011), via a pending agreement that looks to be the start a very lucrative relationship.
USA Recycling Industries, Inc. (USRI) is a mid-market recyclable waste collection & disposal service, providing specialty recycling programs to commercial & industrial customers throughout North America. Operating through multiple company-owned & partnership recycling centers, the company primarily targets growth opportunities in the $75 billion global scrap metals market.
USA Recycling has operated since its inception in 2000, and its largest operating subsidiary, Scrap USA, since 2007 has been focused on and successful in servicing the automotive service center industry. It currently provides specialty recycling programs to more than 5,000 automotive service center locations operated by some of the most recognizable names in that retail category.
With a well-established national footprint, the company is now integrating other ancillary services such as the collection & disposal of other recyclable waste streams. USA Recycling has also opened the door to franchising opportunities and recently signed a proprietary revenue sharing agreement with Recycling Franchisors, Inc. Other initiatives to drive growth and boost prominence include the launch of a new website and relocation of executive offices.
USA Recycling has successfully contracted automotive waste-generators for collection & disposal services, selling the processed recyclable materials to end-user-consumers through the company's trading operations with offices in North America, India, and the United Arab Emirates. The company's primary aim is to maximize shareholder value while providing the highest level of quality waste collection & disposal services to its customers, ensuring its collected debris remain free of any U.S. landfills. Disclaimer
USA Recycling Industries, Inc. Company Blog
USA Recycling Industries, Inc. News:
USA Recycling Industries to Provide Scrap Metal Collection Services to ThyssenKrupp Elevator Americas
USA Recycling Industries Enters Oil Filter Collection and Disposal Services Agreement With Redwood Recycling
USA Recycling Industries Signs Letter of Intent to Expand Used Oil Filter Recycling Operations
Duma Energy Corp. (DUMA)
The QualityStocks Daily Newsletter would like to spotlight Duma Energy Corp. (DUMA). Today, Duma Energy Corp. closed trading at $1.99, up 10.56%, on 2,957 volume with 9 trades. The stock’s average daily volume over the past 60 days is 2,578, and its 52-week low/high is $1.50/$4.00.
Duma Energy Corp. (DUMA) is an aggressive growth company actively producing oil and gas in the domestic United States, both on and offshore. Leveraging its technical expertise, promising portfolio, and strong financial condition, the company plans to utilize domestic revenues and cash flow to fund its rapid growth through acquisition, while participating in transformational projects with the potential of providing exponential returns for shareholders.
The company's primary goal for fiscal year 2012 and beyond is to drive earnings growth. The company also aims to pursue listing on major exchange(s) to provide better visibility and liquidity to shareholders and financial partners. Already producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana, Duma projects domestic production to exceed 1,000 barrels of oil equivalent per day (boepd) by the end of 2012; with 2,500 boepd projected by the end of 2013.
Duma was founded in 2005 and began trading on the OTCBB in 2009 via registration. In 2006, the company began producing from its first properties in Texas and soon after added production in Louisiana. In 2009, its new CEO Jeremy G. Driver came on board. Within one year, Mr. Driver had identified and negotiated an acquisition that would fundamentally reshape the company. This acquisition was made possible by the large direct cash investment by Mr. Driver and his family, as well as other investors.
The company uses only industry standard and time-tested technologies, and avoids unproven "resource plays" and other opportunities that are heavily dependent upon high commodity prices. Not bound by any geographical location or operational strategy, Duma's management team is focused on developing its existing portfolio while pursuing additional opportunities that provide rapid growth, leveraging growing revenue, cash flow, and reserves to accelerate its growth strategy. Disclaimer
Duma Energy Corp. Company Blog
Duma Energy Corp. News:
Duma Energy Provides Third Quarter Results and Demonstrates Positive Earnings
Duma Energy Announces New Trading Symbol "DUMA"
Duma Energy Provides Operational Update for Galveston Bay
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.60, up 6.67%, on 2,093 volume with 2 trades. The stock’s average daily volume over the past 60 days is 6,232, and its 52-week low/high is $1.02/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise to Present at the Inaugural Marcum MicroCap Conference on June 20th in New York City
GlobalWise Signs Channel Sales Partnership With Sycle.net
GlobalWise Announces Success of Partner Advisory Board Event
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.38, up 5.56%, on 19,057 volume with 9 trades. The stock’s average daily volume over the past 60 days is 198,625, and its 52-week low/high is $0.21/$1.15.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Scientists Create New Protein-Based Stem Cell Technology
International Stem Cell Corporation Announces Marketing Plans for Its Wholly Owned Subsidiary Lifeline Skin Care
International Stem Cell Corp Announces First Quarter 2012 Financial Results and Business Highlights
USA Recycling Industries, a Pennsylvania-based scrap metals recycler providing specialty recycling services throughout North America, announced shortly after the closing bell today that it will provide scrap metal collection services to ThyssenKrupp Elevator Americas under a pending agreement covering their branch and site facilities in the United States, Alaska, and Hawaii.
USA Recycling Industries CEO Vincent J. Smith stated, “ThyssenKrupp Elevator Americas, a subsidiary of ThyssenKrupp Elevator AG, is the largest producer of elevators in the Americas, with more than 13,500 employees, more than 200 branch and service locations, and sales of more than $2.7 billion. ThyssenKrupp Elevator Americas oversees all business for operations in the United States, Canada, Central and South America.”
ThyssenKrupp Elevator AG is one of the world’s leading elevator companies with more than 46,000 employees, sales of 5.3 billion Euros in fiscal 2010/2011, and customers in 150 countries. Its portfolio includes passenger and freight elevators, escalators and moving walks, passenger boarding bridges, stair and platform lifts, as well as tailored service solutions for all products. 900 locations around the world provide an extensive sales and service network to guarantee closeness to customers.
“Our company is excited and looking forward to serving ThyssenKrupp Elevator Americas both here in the U.S. and its territories,” concluded Mr. Smith. “The relationship we are developing is expected to be very lucrative while simultaneously leading the charge into new markets and opening the doors for more waste management and recycling opportunities.”
To learn more about the company, visit www.usarecyclingindustriesinc.com
Independence Energy’s business strategy is to advance its line-up of existing oil and gas exploration endeavors through development or offset drilling and to bolster its portfolio through the acquisition of select property interests. The company and its partners today announced they have chosen the first potential drill target at the Coleman South Lease exploration joint development project in Coleman County, Texas.
Independence currently holds a 12.5 percent working interest in the Coleman South Lease project and holds an option to increase its working interest to 25.0 percent. The company will be expected to finance its portion of the well cost in an amount that has not yet been determined.
The Coleman South Lease property is located less than one mile from the Shields-MEI #105H horizontal well, which is currently being drilled and in which the company also holds an interest.
Independence Energy anticipates that the lease project will create a flow of potential drill targets in the near future.
“The development of the 2,400-acre Coleman South Lease project is expected to generate a significant number of new high-potential drill targets for the company over the coming months,” Gregory C. Rotelli, CEO and president of Independence Energy stated in the press release. “The site of this first potential well was chosen because of its ideal location offset from a prolific historical well in the area and because the well has the potential to target multiple known productive geological formations. We anticipate that it could take up to 50 vertical or 15 horizontal wells to fully exploit the property. We expect to have the drilling start date scheduled very soon for this first of hopefully many new wells.”
The company expects that the first drill location at the Coleman South Lease will be an offset of the D. M. Hankins #1 well, which was originally drilled and completed in the Gray Sandstone formation. The Hankins well produced 105,542 barrels of oil and 311,832 MCF of gas.
For more information visit www.independeceenergycorp.com
Scio Diamond Technology employs a patent-protected chemical vapor deposition process to produce high-quality, single-crystal diamonds in a controlled laboratory setting. These lab-grown or cultivated diamonds have the identical chemical, physical, and optical properties as natural diamonds found in the earth. The company intends to sell artificial diamonds to the both the jewelry and the technology sectors.
The company reported today that the first full production run using its S3532 technology of five diamond growing reactors was extremely successful. The five growers ran an average of 179 hours each, producing over 220 gross carats of diamonds. Scio Diamond’s CEO Joe Lancia called it “yet another milestone passed on Scio’s roadmap to the mass production of diamond.”
Two more reactors are scheduled to enter initial full production runs in the next week. Scio expects the balance of the 10 reactors to be in full production by the end of its fiscal second quarter. As production moves toward a “normal” operating schedule, the company will be concentrating on a parallel growth in its diamond fabrication capabilities. These will include precise laser cutting and polishing operations to take the rough-cut diamond to the final product stage.
As Scio eventually builds a self-sustaining seed stock, the company continues to work with clients on their specific diamond requirements. This is a very important point. Scio’s believes it must not just produce diamonds, but produce diamonds to the customers’ specifications, and to do so reliably and with scalability.
To find out more about Scio Diamond Technology and its approach to diamond production, please visit its Web site at www.sciodiamond.com
Curis, a drug development company focused on developing proprietary targeted medicines for cancer treatment, announced today an article regarding CUDC-907 has been published in the journal Clinical Cancer Research. CUDC-907 is an orally-available small molecule drug candidate under development by Curis, and it is designed to simultaneously inhibit PI3K and HDAC. Several members of Curis’ scientific team authored the article, titled “Cancer network disruption by a single molecule inhibitor targeting both histone deacetylase (HDAC) activity and phosphatidylinositol 3-kinase (PI3K) signaling.” The article will be published in the print version of the journal in the near future.
“We are encouraged by the publication of CUDC-907 data in Clinical Cancer Research. We believe that these data support our development strategy for this molecule, under which we plan to initiate a Phase I clinical trial in patients with diffuse large B-cell lymphoma or multiple myeloma later this year,” stated Dan Passeri, Curis President and Chief Executive Officer. “We developed CUDC-907 to target PI3K as well as HDAC, which is known to induce multiple epigenetic modifications affecting signaling networks and also to act synergistically with PI3K inhibitors. The objective of CUDC-907 is to provide for a broad disruption of several pathways that are implicated in hematologic malignancies in order to achieve a better outcome for patients.”
The focus of the article was CUDC-907’s potential for continued development in cancer treatment, specifically in the treatment of hematological cancers. CUDC-907 has shown potent anticancer activity in xenograft models and cultured cancer cells, as well as evidence that it may offer therapeutic benefits for multiple cancer types through broad signaling network disruption. A specific example of these promising capabilities is data showing that CUDC-907 durably inhibits both the primary P13K-AKT-mTOR pathway and also many compensatory signaling molecules which cancer cells often utilize to outmaneuver the mechanisms of single target kinase inhibitors, including RAF, MEK, MAPK, and STAT-3, among others. The scientists at Curis believe that CUDC-907 could possibly deliver improved therapeutic benefit with its simultaneous, sustained disruption of multiple signaling pathways.
Curis’ discovery and development efforts are focused on building a portfolio of small molecule network-targeted inhibitors against a wide range of cancer types. The leading compounds within Curis’ research and development programs are designed to inhibit one or more cancer targets, including EGFR, Her2, and PI3K, as well as the inhibition of histone deacetylase, or HDAC, a validated non-kinase cancer target. Each target combination is chosen for its potential of mechanistic synergy, offering a differentiated, potential breakthrough approach to cancer therapy, intended to disrupt cancer resistance networks.
For more information, please visit www.curis.com
Today's Top 3
The QualityStocks Public Company Sponsor News